Showing results (1311-1320 of 2,709) with videos related to

Sort By:
Pageof 271
The Lancet. Infectious Diseases|May 11, 2026
Dihydroartemisinin-piperaquine versus chloroquine for the treatment of uncomplicated Plasmodium vivax malaria with concurrent or delayed high-dose primaquine in Brazil (Curavivax): an open-label, single-centre, randomised clinical trialDjane C Baía-da-Silva, Kim Vinícius AmaralC Machado, Amanda Lia RebêloC Rabelo, et al.
The Lancet. Infectious Diseases|October 28, 2006
Hookworm vaccines: past, present, and futureAlex Loukas, Jeffrey Bethony, Simon Brooker, et al.
The Lancet. Infectious Diseases|July 28, 2006
Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study designHannah B Ibanga, Roger H Brookes, Philip C Hill, et al.
The Lancet. Infectious Diseases|February 2, 2010
Serogroup B meningococcal vaccines-an unfinished storyManish Sadarangani, Andrew J Pollard
The Lancet. Infectious Diseases|June 9, 2026
Calciphylaxis complicated by NDM-1-producing Pseudomonas aeruginosa: first experience with cefepime-zidebactam alongside phage therapy in the USAErlinda R Ulloa, Daniel Jaffurs, M Tuan Tran, et al.
The Lancet. Infectious Diseases|June 1, 2026
Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing developmentFrancesca Saluzzo, Seda Yerlikaya, Susan Elizabeth Dorman, et al.
The Lancet. Infectious Diseases|June 30, 2022
Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trialMark F Cotton, Shabir A Madhi, Angelique K Luabeya, et al.
The Lancet. Infectious Diseases|October 22, 2022
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trialSaye H Khoo, Richard FitzGerald, Geoffrey Saunders, et al.
The Lancet. Infectious Diseases|October 27, 2019
Extended-spectrum β-lactamase-producing Escherichia coli in human-derived and foodchain-derived samples from England, Wales, and Scotland: an epidemiological surveillance and typing studyMichaela J Day, Katie L Hopkins, David W Wareham, et al.
The Lancet. Infectious Diseases|May 28, 2005
A synthesis of cost-utility analysis literature in infectious diseasePatricia W Stone, Bruce R Schackman, Christopher P Neukermans, et al.
Pageof 271